 Secondary Prevention
"Secondary Prevention" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The prevention of recurrences or exacerbations of a disease or complications of its therapy.
| Descriptor ID |
D055502
|
| MeSH Number(s) |
E02.897 N02.421.726.825 N06.850.780.750
|
| Concept/Terms |
Secondary Prevention- Secondary Prevention
- Prevention, Secondary
- Preventions, Secondary
- Secondary Preventions
- Secondary Disease Prevention
- Disease Prevention, Secondary
- Disease Preventions, Secondary
- Prevention, Secondary Disease
- Preventions, Secondary Disease
- Secondary Disease Preventions
Relapse Prevention- Relapse Prevention
- Prevention, Relapse
- Preventions, Relapse
- Relapse Preventions
Early Therapy- Early Therapy
- Early Therapies
- Therapies, Early
- Therapy, Early
|
Below are MeSH descriptors whose meaning is more general than "Secondary Prevention".
Below are MeSH descriptors whose meaning is more specific than "Secondary Prevention".
This graph shows the total number of publications written about "Secondary Prevention" by people in this website by year, and whether "Secondary Prevention" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 | | 2000 | 0 | 3 | 3 | | 2001 | 0 | 2 | 2 | | 2002 | 0 | 5 | 5 | | 2003 | 0 | 3 | 3 | | 2005 | 0 | 2 | 2 | | 2006 | 0 | 5 | 5 | | 2007 | 0 | 9 | 9 | | 2008 | 0 | 5 | 5 | | 2009 | 0 | 3 | 3 | | 2010 | 0 | 13 | 13 | | 2011 | 1 | 5 | 6 | | 2012 | 3 | 6 | 9 | | 2013 | 4 | 7 | 11 | | 2014 | 4 | 9 | 13 | | 2015 | 9 | 6 | 15 | | 2016 | 7 | 14 | 21 | | 2017 | 10 | 10 | 20 | | 2018 | 8 | 9 | 17 | | 2019 | 7 | 8 | 15 | | 2020 | 5 | 5 | 10 |
To return to the timeline, click here.
Below are the most recent publications written about "Secondary Prevention" by people in Profiles.
-
Kent DM, Saver JL, Ruthazer R, Furlan AJ, Reisman M, Carroll JD, Smalling RW, Jüni P, Mattle HP, Meier B, Thaler DE. Risk of Paradoxical Embolism (RoPE)-Estimated Attributable Fraction Correlates With the Benefit of Patent Foramen Ovale Closure: An Analysis of 3 Trials. Stroke. 2020 10; 51(10):3119-3123.
-
Anglemyer A, Moore TH, Parker L, Chambers T, Grady A, Chiu K, Parry M, Wilczynska M, Flemyng E, Bero L. Digital contact tracing technologies in epidemics: a rapid review. Cochrane Database Syst Rev. 2020 08 18; 8:CD013699.
-
Johnson JL, Capin JJ, Arundale AJH, Zarzycki R, Smith AH, Snyder-Mackler L. A Secondary Injury Prevention Program May Decrease Contralateral Anterior Cruciate Ligament Injuries in Female Athletes: 2-Year Injury Rates in the ACL-SPORTS Randomized Controlled Trial. J Orthop Sports Phys Ther. 2020 Sep; 50(9):523-530.
-
Izmirly P, Kim M, Friedman DM, Costedoat-Chalumeau N, Clancy R, Copel JA, Phoon CKL, Cuneo BF, Cohen RE, Robins K, Masson M, Wainwright BJ, Zahr N, Saxena A, Buyon JP. Hydroxychloroquine to Prevent Recurrent Congenital Heart Block in Fetuses of Anti-SSA/Ro-Positive Mothers. J Am Coll Cardiol. 2020 07 21; 76(3):292-302.
-
Furtado RHM, Venkateswaran RV, Nicolau JC, Gurmu Y, Bhatt DL, Storey RF, Steg PG, Magnani G, Goto S, Dellborg M, Kamensky G, Isaza D, Aylward P, Johanson P, Bonaca MP. Caffeinated Beverage Intake, Dyspnea With Ticagrelor, and Cardiovascular Outcomes: Insights From the PEGASUS-TIMI 54 Trial. J Am Heart Assoc. 2020 05 18; 9(10):e015785.
-
Gencer B, Li XS, Gurmu Y, Bonaca MP, Morrow DA, Cohen M, Bhatt DL, Steg PG, Storey RF, Johanson P, Wang Z, Hazen SL, Sabatine MS. Gut Microbiota-Dependent Trimethylamine N-oxide and Cardiovascular Outcomes in Patients With Prior Myocardial Infarction: A Nested Case Control Study From the PEGASUS-TIMI 54 Trial. J Am Heart Assoc. 2020 05 18; 9(10):e015331.
-
Marquis-Gravel G, Roe MT, Robertson HR, Harrington RA, Pencina MJ, Berdan LG, Hammill BG, Faulkner M, Muñoz D, Fonarow GC, Nallamothu BK, Fintel DJ, Ford DE, Zhou L, Daugherty SE, Nauman E, Kraschnewski J, Ahmad FS, Benziger CP, Haynes K, Merritt JG, Metkus T, Kripalani S, Gupta K, Shah RC, McClay JC, Re RN, Geary C, Lampert BC, Bradley SM, Jain SK, Seifein H, Whittle J, Roger VL, Effron MB, Alvarado G, Goldberg YH, VanWormer JL, Girotra S, Farrehi P, McTigue KM, Rothman R, Hernandez AF, Jones WS. Rationale and Design of the Aspirin Dosing-A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE) Trial. JAMA Cardiol. 2020 05 01; 5(5):598-607.
-
Messé SR, Gronseth GS, Kent DM, Kizer JR, Homma S, Rosterman L, Carroll JD, Ishida K, Sangha N, Kasner SE. Practice advisory update summary: Patent foramen ovale and secondary stroke prevention: Report of the Guideline Subcommittee of the American Academy of Neurology. Neurology. 2020 05 19; 94(20):876-885.
-
Rymer JA, Kennedy KF, Lowenstern AM, Secemsky EA, Tsai TT, Aronow HD, Prasad A, Gray B, Armstrong EJ, Rosenfield K, Shishehbor MH, Jones WS. In-Hospital Outcomes and Discharge Medication Use Among Patients With Critical Limb Ischemia Versus Claudication. J Am Coll Cardiol. 2020 02 18; 75(6):704-706.
-
Goldenberg NA, Branchford BR. The phase 3 pediatric anticoagulant era. Blood. 2020 02 13; 135(7):459-460.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|